LPC
GSK icon

Loeb Partners Corp’s GSK GSK Stock Holding History

Loeb Partners Corp’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,000
Closed -$267K – 176
2014
Q2 		$267K Hold
4,000
– – 0.08% 155
2014
Q1 		$267K Hold
4,000
– – 0.09% 154
2013
Q4 		$267K Sell
4,000
-5,600
-58% -$363K 0.09% 167
2013
Q3 		$602K Buy
+9,600
New +$618K 0.2% 107

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Loeb Partners Corp's GSK Position: Q3 2014 in Review

Loeb Partners Corp sold out of GSK (GSK) in Q3 2014, closing a stake of 4,000 shares — an estimated $267K sold.

Loeb Partners Corp first reported a position in GSK in Q3 2013 and held it in 4 quarters. The position peaked at $602K in Q3 2013. 701 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

  • Loeb Partners Corp reported no remaining GSK position as of Q3 2014 after selling out during the quarter.
  • Loeb Partners Corp sold 4,000 GSK shares in Q3 2014, an estimated $267K.
  • Loeb Partners Corp first reported a position in GSK in Q3 2013 and held it in 4 quarters.
  • Loeb Partners Corp's GSK position peaked at $602K in Q3 2013.
  • 701 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on Loeb Partners Corp's 13F filing for Q3 2014, filed 12 Nov 2014.